Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ACAD

Acadia Pharmaceuticals Inc

May 14 • 04:00PM ET

22.09

-0.09 -0.41 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ALKS AXSM NBIX SUPN PRTA

| Held by: IJR VTI XBI IWM VB VBK VXF IBB SPSM IJT

Scroll to Statements

Index	RUT	P/E	10.06	EPS (ttm)	2.20	Insider Own	1.50%	Shs Outstand	171.09M	Perf Week	-2.08%
Market Cap	3.78B	Forward P/E	28.74	EPS next Y	0.77	Insider Trans	-2.21%	Shs Float	168.66M	Perf Month	1.52%
Enterprise Value	2.98B	PEG	-	EPS next Q	0.06	Inst Own	96.95%	Short Float	6.61%	Perf Quarter	2.22%
Income	375.65M	P/S	3.45	EPS this Y	-83.06%	Inst Trans	-1.83%	Short Ratio	5.81	Perf Half Y	-6.87%
Sales	1.10B	P/B	3.03	EPS next Y	97.30%	ROA	27.44%	Short Interest	11.16M	Perf YTD	-17.30%
Book/sh	7.29	P/C	4.44	EPS next 5Y	-14.49%	ROE	37.32%	52W High	28.35 -22.08%	Perf Year	28.73%
Cash/sh	4.97	P/FCF	33.30	EPS past 3/5Y	- -	ROIC	29.19%	52W Low	16.97 30.18%	Perf 3Y	2.89%
Dividend Est.	-	EV/EBITDA	32.16	Sales past 3/5Y	27.48% 19.39%	Gross Margin	91.47%	Volatility	3.03% 3.25%	Perf 5Y	1.47%
Dividend TTM	-	EV/Sales	2.72	EPS Y/Y TTM	61.40%	Oper. Margin	7.39%	ATR (14)	0.77	Perf 10Y	-21.42%
Dividend Ex-Date	-	Quick Ratio	3.48	Sales Y/Y TTM	9.93%	Profit Margin	34.30%	RSI (14)	49.99	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.59	EPS Q/Q	-81.36%	SMA20	-0.21%	Beta	0.85	Target Price	31.65
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.72%	SMA50	1.13%	Rel Volume	1.01	Prev Close	22.18
Employees	798	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-6.88%	Avg Volume	1.92M	Price	22.09
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.40% -4.34%	Trades		Volume	2,027,235	Change	-0.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)